A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days
Nature Medicine2013Vol. 19(11), pp. 1542–1546
Citations Over TimeTop 10% of 2013 papers
Eiji Kobayashi, Eishiro Mizukoshi, Hiroyuki Kishi, Tatsuhiko Ozawa, Hiroshi Hamana, T Nagai, Hidetoshi Nakagawa, Aishun Jin, Shuichi Kaneko, Atsushi Muraguchi
Related Papers
- → B7-H3/CD276: An Emerging Cancer Immunotherapy(2021)282 cited
- → New opportunities for nanoparticles in cancer immunotherapy(2018)214 cited
- → Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators(2020)80 cited
- → Characterization of an HIV-1 p24gag epitope recognized by a CD8+ cytotoxic T-cell clone(1997)11 cited
- → Change in the Fine Specificity of a Human Cytotoxic T Cell Clone Under α-Interferon Treatment(1989)